Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-02-25 @ 6:52 PM
Study NCT ID:
NCT04214808
Status:
COMPLETED
Last Update Posted:
2020-12-02
First Post:
2019-12-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate the Pharmacokinetics and Safety of AD-208
Sponsor:
Addpharma Inc.
Organization:
Study Overview
Official Title:
A Randomized, Open-label, Single-dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of AD-208
Status:
COMPLETED
Status Verified Date:
2020-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate pharmacokinetics and safety of AD-208.
Detailed Description:
The purpose is that pharmacokinetics and safety of AD-208 in healthy adult male volunteers are evaluated as compared to Avodart Soft Capsule 0.5mg.
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: